Clinical practice guidelines for the management of atopic dermatitis 2018

Norito Katoh, Yukihiro Ohya, Masanori Ikeda, Tamotsu Ebihara, Ichiro Katayama, Hidehisa Saeki, Naoki Shimojo, Akio Tanaka, Takeshi Nakahara, Mizuho Nagao, Michihiro Hide, Yuji Fujita, Takao Fujisawa, Masaki Futamura, Koji Masuda, Hiroyuki Murota, Kiwako Yamamoto-Hanada

Research output: Contribution to journalArticlepeer-review

84 Citations (Scopus)


Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.

Original languageEnglish
Pages (from-to)1053-1101
Number of pages49
JournalJournal of Dermatology
Issue number12
Publication statusPublished - Dec 1 2019

All Science Journal Classification (ASJC) codes

  • Dermatology


Dive into the research topics of 'Clinical practice guidelines for the management of atopic dermatitis 2018'. Together they form a unique fingerprint.

Cite this